Associate Sponsors

Co-sponsor

Investment Strategy

How can your portfolio outperform markets? Sandeep Neema shares strategy

The next phase of returns in Indian equities will be increasingly driven by companies demonstrating strong earnings visibility, says Sandeep Neema of PL Capital

Updated On: 24 Feb 2026 | 8:00 AM IST

Look for strength in despair to find the next market leaders: Harini Dedhia

52-week low lists become a common hunting ground to find investments among those that were the darlings of the market in the most recent run-up prior to the correction

Updated On: 29 Jan 2026 | 10:11 AM IST

Smallcaps may see more pain in 2026; Nifty target at 30,548: Vikram Kasat

Mid-caps are poised to lead over large- and small-caps in 2026, driven by double-digit FY27 earnings and FPI inflows, though outperformance margins may narrow, said Vikram Kasat of PL Capital

Updated On: 15 Dec 2025 | 8:41 AM IST

Muhurat Trading 2025: What should be your trading strategy today?

Muhurat Trading: The special one-hour Muhurat session, considered a symbolic start to the Hindu calendar year (Samvat 2082), will be held between 1:45 PM and 2:45 PM today on both the NSE and BSE.

Updated On: 21 Oct 2025 | 9:53 AM IST

Nomura keeps Nifty target at 26,140, backs Swiggy, Titan, Alkem as top bets

Nomura has maintained its Nifty target for March 2026 at 26,140, implying a modest upside of 4 per cent from current levels, based on a FY27F earnings per share (EPS) estimate of ₹1,245.

Updated On: 16 Oct 2025 | 9:41 AM IST

PL Capital sees Nifty at 28,781 in 1 yr; banks, auto, defence to lead rally

Analysts at PL Capital expect domestic-oriented sectors to outperform, naming banks, NBFCs, autos, retail, consumer staples, defence, metals, and select consumer durables as top picks.

Updated On: 15 Oct 2025 | 8:12 AM IST

Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here

Analysts at Nomura continue to back Glenmark Pharma, citing the company's ability to strategically acquire high-potential innovative products.

Updated On: 25 Sep 2025 | 12:19 PM IST

Tata Motors shares drop 5% in 2 days as JLR cyberattack rattles investors

On Thursday, September 25, 2025, the Tata Motors stock fell as much as 2.59 per cent to an intraday low of ₹665 per share.

Updated On: 25 Sep 2025 | 11:22 AM IST

Sun Pharmaceutical: Domestic, innovation push eyed; Nuvama maintains 'Hold'

Sun Pharma aims to strengthen its domestic formulations business through field force expansion and a generic GLP-1 launch in CY26.

Updated On: 25 Sep 2025 | 8:30 AM IST

Camlin Fine shares can double your money in 1 year, says InCred Equities

On the bourses at 1:01 PM, Camlin Fine Sciences share price was trading 0.28 per cent lower at ₹231.85 per share. By comparison, BSE Sensex was trading 0.21 per cent lower at 82,451.90 levels.

Updated On: 22 Sep 2025 | 1:02 PM IST

Prince Pipes share skyrockets 36% in 6 months; analysts see 31% more upside

While the near-term demand environment remains muted due to volatile PVC prices and weak trade sentiment, Prince Pipes remains confident of delivering high single-digit volume growth in FY26.

Updated On: 19 Sep 2025 | 8:57 AM IST

Real estate stocks burn investor pockets in 2025; is rebound on the cards?

Real estate sector/stocks: The Nifty Realty index has slumped nearly 14 per cent so far in 2025 (till Sept 15), in sharp contrast to the 6 per cent gain in the benchmark Nifty50 index.

Updated On: 18 Sep 2025 | 11:18 AM IST

RIL, Bharti Airtel set to dominate India's $8bn data centre boom: Jefferies

India's data centre capacity is expected to quintuple to 8GW over the next 5 years, driven by rising internet traffic, growing adoption of AI & stricter regulatory mandates around data localisation.

Updated On: 16 Sep 2025 | 11:52 AM IST

Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?

Among stocks, Natco Pharma plunged 37.85%, Ipca Labs 22.43%, Aurobindo Pharma 17.99%, and Sun Pharma 14.30%. Other laggards include Lupin (13.25%), and Dr Reddy's (5.17%).

Updated On: 15 Sep 2025 | 10:26 PM IST

Analysts see 23% upside in Pidilite Industries; retain 'Buy'; do you own?

Pidilite Industries share price has gained 13.1 per cent in the last six months. In comparison, BSE Sensex has gained a little over 10 per cent during the same period.

Updated On: 12 Sep 2025 | 9:23 AM IST

HSBC upgrades NTPC to 'Buy' on multiple growth levers, lifts target to ₹400

The upgrade came on the back of recent correction in NTPC's stock price, with HSBC also raising its target price to ₹400 from ₹385 earlier.

Updated On: 11 Sep 2025 | 2:49 PM IST

4 reasons HDFC Securities recommends 'Add' on JK Cement, raises target

JK Cement share price today: On the bourses, JK Cement share price rose up to 1.21 per cent to an intraday high of ₹6,660 per share.

Updated On: 11 Sep 2025 | 1:30 PM IST

Cummins India up 40% in 6 months; hits 52-week high as Nomura lifts target

Cummins India share has gained 40.3 per cent over the past six months, rising 18.5 per cent in the last three months and over 5 per cent in the past month alone, BSE data showed.

Updated On: 10 Sep 2025 | 10:15 AM IST

Eureka Forbes can double in 3-4 years, says Emkay; stock up over 2% today

Emkay initiated coverage on Eureka Forbes stock with a target price of ₹725, implying about 24 per cent upside.

Updated On: 05 Sep 2025 | 10:34 AM IST

Motilal Oswal sees buffet of tailwinds; upgrades Swiggy, bullish on Eternal

The brokerage now values Swiggy at ₹560, capturing the inflection in food delivery growth and the path to improved economics in Instamart.

Updated On: 05 Sep 2025 | 9:13 AM IST